Last $1.56 USD
Change Today -0.0201 / -1.27%
Volume 344.8K
As of 12:40 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce Allan Chabner M.D.

Medical and Scientific Advisor, Peregrine Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 71 board members in 6 different organizations across 9 different industries.

See Board Relationships
73--

Background*

Dr. Bruce Allan Chabner, M.D. is an Advisor of Thomas, McNerney & Partners. Dr. Chabner serves as Scientific Advisor of Lumicell, Inc. Dr. Chabner serves as Medical and Scientific Advisor at Peregrine Pharmaceuticals Inc. Dr. Chabner serves as an Associate Director of Clinical Science at the Dana-Farber/Harvard Cancer Center since 1999, which includes the Massachusetts General Hospital, Brigham & Women's Hospital, Dana-Farber Cancer Institute, and Beth Israel Deaconess ...

Read Full Background

Corporate Headquarters*

14282 Franklin Avenue
Tustin, California 92780

United States

Phone: 714-508-6000
Fax: --

Board Members Memberships*

Former Director
Director
2001-Present
Director and Member of Compensation Committee

Education*

MD 1965
Harvard Medical School
BA 1961
Yale College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPHM:US $1.56 USD -0.0201

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEREGRINE PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.